Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

Q: What does CUSIP 86366E106 represent in this 13F holders report?

CUSIP 86366E106 is the security identifier for GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in Q1 2024?

119 institutional investors reported GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 86366E106

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding: 213,001,347
Total 13F shares: 43,607,566
Share change: +979,839
Total reported value: $1,861,796,908
Put/Call ratio: 33%
Price per share: $42.86
Number of holders: 119
Value change: +$49,174,094
Number of buys: 68
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 86366E106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	4,372,326	$178,216,008	—	31 Dec 2023	13F
FMR LLC	13F	Company	1.9%	4,034,584	$164,449,644	—	31 Dec 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	1.2%	2,599,079	$105,938,460	—	31 Dec 2023	13F
Avoro Capital Advisors LLC	13F	Company	1.1%	2,333,333	$95,106,653	—	31 Dec 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.1%	2,267,206	$92,411,317	—	31 Dec 2023	13F
TCG Crossover Management, LLC	13F	Company	0.99%	2,109,584	$85,986,644	—	31 Dec 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.82%	1,756,918	$71,611,978	—	31 Dec 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.79%	1,679,436	$68,454,000	—	31 Dec 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.73%	1,544,416	$62,838,123	—	31 Dec 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	0.62%	1,312,195	$53,486,000	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.54%	1,152,985	$46,995,668	—	31 Dec 2023	13F
Casdin Capital, LLC	13F	Company	0.51%	1,091,867	$44,504,499	—	31 Dec 2023	13F
HSG Holding Ltd	13F	Company	0.5%	1,065,226	$44,100,357	—	31 Dec 2023	13F
Avidity Partners Management LP	13F	Company	0.51%	1,080,000	$44,020,800	—	31 Dec 2023	13F
Logos Global Management LP	13F	Company	0.5%	1,070,058	$43,615,564	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	0.5%	1,061,058	$43,248,724	—	31 Dec 2023	13F
Capital Research Global Investors	13F	Company	0.46%	973,535	$39,681,287	—	31 Dec 2023	13F
Capital International Investors	13F	Company	0.4%	850,024	$34,646,978	—	31 Dec 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.39%	822,813	$33,537,858	—	31 Dec 2023	13F
BVF INC/IL	13F	Company	0.38%	812,988	$33,137,391	—	31 Dec 2023	13F
Capital World Investors	13F	Company	0.3%	634,160	$25,848,362	—	31 Dec 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.25%	542,323	$22,105,094	—	31 Dec 2023	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.23%	486,832	$19,843,272	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	427,735	$17,434,479	—	31 Dec 2023	13F
Ramy Farid	3/4/5	Director	— mixed-class rows	3,535,495 mixed-class rows	$17,176,500	—	07 Feb 2023	3/4/5
Octagon Capital Advisors LP	13F	Company	0.19%	414,000	$16,874,640	—	31 Dec 2023	13F
Boxer Capital, LLC	13F	Company	0.19%	400,000	$16,304,000	—	31 Dec 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.15%	317,190	$12,928,664	—	31 Dec 2023	13F
Deep Track Capital, LP	13F	Company	0.14%	300,000	$12,228,000	—	31 Dec 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.14%	291,097	$11,865,114	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.13%	287,069	$11,700,948	—	31 Dec 2023	13F
Rock Springs Capital Management LP	13F	Company	0.13%	286,676	$11,684,914	—	31 Dec 2023	13F
BRAIDWELL LP	13F	Company	0.13%	280,158	$11,419,240	—	31 Dec 2023	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.13%	278,732	$11,361,116	—	31 Dec 2023	13F
MPM BioImpact LLC	13F	Company	0.11%	230,696	$9,403,169	—	31 Dec 2023	13F
S.c.a. Candriam	13F	Individual	0.1%	210,000	$8,559,987	—	31 Dec 2023	13F
Invesco Ltd.	13F	Company	0.09%	195,627	$7,973,756	—	31 Dec 2023	13F
Monashee Investment Management LLC	13F	Company	0.09%	191,855	$7,820,010	—	31 Dec 2023	13F
Woodline Partners LP	13F	Company	0.08%	179,219	$7,304,966	—	31 Dec 2023	13F
Alyeska Investment Group, L.P.	13F	Company	0.08%	178,677	$7,282,875	—	31 Dec 2023	13F
Sofinnova Investments, Inc.	13F	Company	0.08%	174,838	$7,126,397	—	31 Dec 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.07%	157,258	$6,409,836	—	31 Dec 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.07%	150,000	$6,114,000	—	31 Dec 2023	13F
Pictet Asset Management Holding SA	13F	Company	0.07%	138,797	$5,657,366	—	31 Dec 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	125,447	$5,113,220	—	31 Dec 2023	13F
BAMCO INC /NY/	13F	Company	0.06%	118,333	$4,823,253	—	31 Dec 2023	13F
MARSHALL WACE, LLP	13F	Company	0.05%	105,770	$4,311,185	—	31 Dec 2023	13F
Artal Group S.A.	13F	Company	0.04%	86,600	$3,530,000	—	31 Dec 2023	13F
GMT CAPITAL CORP	13F	Company	0.04%	81,700	$3,330,092	—	31 Dec 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.04%	77,093	$3,142,311	—	31 Dec 2023	13F

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q1 2024

As of 31 Mar 2024, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,607,566 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Driehaus Capital Management LLC, FEDERATED HERMES, INC., JANUS HENDERSON GROUP PLC, TCG Crossover Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, RA CAPITAL MANAGEMENT, L.P., and Alyeska Investment Group, L.P.. This page lists 119 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

121

Q1 2024 holders

119

Holder diff

-2

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.